Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc., trading under the ticker PWUP, is a biopharma-focused entity that emerged from the SPAC lifecycle and filed a Form 10-Q with the SEC on November 14, 2024, with accession number 0001493152-24-045850. The company operates in the life sciences and biopharmaceutical sector, reflecting the continued post-combination reporting obligations that follow a de-SPAC transaction. As an active public registrant, Aspire Biopharma Holdings maintains its quarterly disclosure cadence under SEC reporting requirements. Investors and analysts tracking PWUP's financial position, pipeline developments, and corporate governance can sign up for full data, filings, and deal-timeline analytics at SpacDesk.